ストックスクリーナーアプリを入手
0.00
100.00%
-15.82
アフターアワーズ：
15.90
15.90
+
前日終値:
$15.82
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$11.76M
収益：
$31,800
当期純損益:
$-37.83M
株価収益率:
0.00
EPS:
-0.71
ネットキャッシュフロー:
$-30.64M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$17.18
52週間の値動き範囲:
$0.00
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
EYEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.00 | 11.76M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.36 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.75 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.50 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
538.64 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.47 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | 開始されました | Northland Capital | Outperform |
| 2020-02-03 | ダウングレード | Oppenheimer | Outperform → Perform |
Eyenovia Inc (EYEN) 最新ニュース
HYPE Price Drops Below $40 Despite $50M Eyenovia Investment - The Currency analytics
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - The Malaysian Reserve
Eyenovia Bets On Crypto Hype To Revive Struggling Stock - FinanceFeeds
Eyenovia (EYEN) Advances Digital Strategy with Key Developments - GuruFocus
$50 Million Gamble or Genius Move? Eyenovia’s Big Blockchain Bet - Bitcoin.com News
Eyenovia (EYEN) Advances Digital Strategy with Key Developments | EYEN Stock News - GuruFocus
Eyenovia secures debt restructuring as it builds HYPE token treasury By Investing.com - Investing.com Nigeria
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group | EYEN Stock News - GuruFocus
Eyenovia appoints strategic advisor for digital asset treasury strategy - TipRanks
Eyenovia Announces Appointment of a Strategic Advisor for - GlobeNewswire
Eyenovia Secures Major Win: 33% Lower Interest Rate and Top Crypto Advisor Join Forces - Stock Titan
Hyperliquid price outlook amid Eyenovia’s $50M HYPE treasury strategy - CoinJournal
Top Premarket Decliners - MarketScreener
Eyenovia unveils $50M HYPE token strategy; shares drop - MSN
Eyenovia (EYEN) Secures $50 Million Private Placement for Blockchain Initiative - GuruFocus
Eyenovia to invest $50M in Hyperliquid tokens - MSN
Eyenovia Launches $50 Million HYPE Treasury, Announces Rebrand to Hyperion DeFi - BeInCrypto
Nasdaq-Listed Eyenovia Announces to Add $HYPE in Treasury Reserve - The Crypto Times
HYPE drops 6% amid Eyenovia plans to establish Hyperliquid treasury - FXStreet
Eyenovia (EYEN) Secures $50M to Boost Blockchain Initiative | EY - GuruFocus
Eyenovia Invests $50 Million to Establish HYPE Reserve, Company Will Change Name to 'Hyperion DeFi' - Binance
Eyenovia stock soars after $50 million investment for cryptocurrency strategy By Investing.com - Investing.com Nigeria
Eyenovia Inc Announces $50 Million Private Placement In Public Equity - marketscreener.com
Eyenovia (EYEN) Secures $50M Investment for Blockchain Expansion | EYEN Stock News - GuruFocus
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens - Investing.com
Eyenovia to acquire $50 million in HYPE cryptocurrency tokens By Investing.com - Investing.com India
Eyenovia to change name to Hyperion DeFi, ticker to ‘HYPD’ - TipRanks
Eyenovia announces $50M PIPE financing to launch Hyperliquid reserve strategy - TipRanks
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy | EYEN Stock News - GuruFocus
Eyenovia Announces $50 Million Investment to Launch a - GlobeNewswire
Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia - Ophthalmology Times
Eyenovia (EYEN) Stock Skyrockets Over 23% on Nasdaq, Showing Explosive Short-Term Rally - Daily Chhattisgarh News
Eyenovia (EYEN) Stock Explodes Following Amended Loan Agreement Terms: What's Going On? - Benzinga
eyenovia amends loan agreement, limits stock conversion option By Investing.com - Investing.com Canada
Eyenovia On May 30, Enters Third Amendment To Loan And Security AgreementSEC Filing - MarketScreener
eyenovia amends loan agreement, limits stock conversion option - Investing.com
Eyenovia Amends Loan Agreement with Avenue Capital - TipRanks
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities - GlobeNewswire Inc.
Larry Childress buying at Fireweed Metals (FWZ) - The Globe and Mail
Eyenovia provides update on potential merger and Optejet development - MSN
Eyenovia Provides Updates on Potential Merger with Betaliq and D - GuruFocus
Eyenovia Advances Merger Talks With Betaliq And Targets FDA Filing For Optejet Device - Nasdaq
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Eyenovia Reports Q1 2025 Progress and Financials - TipRanks
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing By Investing.com - Investing.com South Africa
Eyenovia advances on merger talks, cuts cash burn, eyes September FDA filing - Investing.com Australia
Eyenovia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Eyenovia (EYEN) Pursues Merger with Betaliq and Advances Optejet Device | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results | EYEN Stock News - GuruFocus
Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - The Manila Times
Eyenovia, Inc. Provides Merger Update with Betaliq and Financial Results for Q1 2025 - Nasdaq
Eyenovia Inc (EYEN) 財務データ
収益
当期純利益
現金流量
EPS
Eyenovia Inc (EYEN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Rowe Michael M | Chief Executive Officer |
Aug 26 '24 |
Buy |
0.57 |
50,000 |
28,500 |
82,927 |
3.56%
0.22%
大文字化:
|
ボリューム (24 時間):